Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit
| Autor: | Grössmann, N., Del Paggio, J.C., Wolf, S., Sullivan, R., Booth, C.M., Rosian, K., Emprechtinger, R., Wild, C. |
|---|---|
| Zdroj: | In European Journal of Cancer September 2017 82:66-71 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect